RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.931501
Abstract: Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. RAB39B, a member of the Ras-oncogene superfamily, is associated with a variety of tumors. Nevertheless,… read more here.
Keywords: cell; lymphoma; dlbcl; rab39b expression ... See more keywords